BridgeBio Oncology Therapeutics is trading 8.76% higher at $3.60 in pre-market on October 12; the reason for the move remains unclear. - The stock closed at $3.31 on October 9. - Available search results show no fresh company announcement explaining the rise; the most recent identified company release is dated September 8. - Major U.S. indices are little changed pre-market. No specific catalyst or trading-volume data was identified, and pre-market activity can be less liquid.